NR0B2 and viral infectious disease: The immunosuppressive effect of SHP may enhance the viral infection, but at the same time it weakens the augmentation of immune response (Kim et al. 2019) as well as the progression of hypercytokinemia, a hallmark of Covid-19 severity (Jiang et al. 2022).